College of Pharmacy
Apotex Centre, 750 McDermot Ave. W.
University of Manitoba
Winnipeg, MB R3E 0T5
Max Rady College of Medicine
Liver disease research group
The focus of Dr. Gong’s research program is on investigation of liver diseases such as fibrosis, hepatocellular carcinoma and cholangiocarcinoma as well as development of vaccine and short interfering RNA to inhibit the expression of several cytokines such as transforming growth factor beta and bone morphogenetic proteins. Other research interests include stem cell differentiation, isolation of different types of cells from the liver, recombinant DNA technology.
In collaboration with investigators in China, Dr. Gong is investigating mechanisms of fatty liver diseases and chronic kidney diseases and developing therapeutic products from Chinese herbal medicine.
The research in Dr. Gong’s laboratory has been supported by the Health Science Foundation, the Manitoba Medical Service Foundation, private pharmaceutical companies, the Canadian Institute of Health Research (CIHR) and the Natural Science and Engineering Research Council (NSERC).
The research collaboration with the China-Japan Friendship Hospital in Beijing China has also resulted in research funding in China from National Natural Science Foundation of China and the Ministry of Science and Technology of Chinese Government to investigate traditional Chinese herbal medicines and diseases in the liver and kidney.
Dr. Yuewen Gong is a professor at the College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba with a cross-appointment in Department of Internal Medicine of the Max Rady College of Medicine, Rady Faculty of Health Sciences. Over the past ten years Dr. Gong has been an assistant professor, associate professor and professor at the University of Manitoba.
Dr. Gong has published more than 100 peer-reviewed papers in various journals including Gastroenterology, Hepatology, Cancer Research, Endocrinology, Journal of Cellular Physiology, American Journal of Physiology, Journal of Pharmacy and Pharmaceutical Sciences.
He has also published more than more than 90 conference abstracts. His work has been cited more than 3,138 times by other colleagues and h-index is 33 according to Google Scholar.
Dr. Gong has given more than 60 invited seminars/keynote presentations to a variety of academic institutes, government agencies and high-profile international conferences.
After graduation he completed postdoctoral training at the Mayo Clinic and the University of Manitoba.
Visit Yuewen Gong’s ORCID profile for a complete listing.